Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2025-12-25 @ 12:46 AM
NCT ID:
NCT00896467
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed cancer
* Metastatic disease for which the median progression-free survival is ≥ 4 months
* Breast, digestive, kidney, lung
* Receiving first-line antitumor therapy (i.e., chemotherapy or targeted therapy) as part of either:
* Phase II or III randomized clinical trial
* Standard treatment off-trial
PATIENT CHARACTERISTICS:
* WHO performance status (PS) 0-3 or Karnofsky PS 50-100%
* No psychological or physical inability to respond to a questionnaire
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No psychotropic treatment, except for antidepressants, anxiolytics, or sleeping pills taken for more than 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00896467
Study Brief:
Protocol Section:
NCT00896467